Abstract
In a previous study, we reported on a selective and long-lasting paradoxical sleep (PS) deprivation in cats following repeated administration of the Parkinson syndrome-inducing neurotoxin N-methyl-4-pheny11,2,3,6-tetrahydropyridine (MPTP). While the characteistic motor deficits occurred only from the 2nd to 3rdday of a 5-day long administration of 5 mg/kg per day MPTP i.p., the PS deprivation started immediately after the first injection and lasted altogether for 11–13 days. The motor deficiencies induced by repeated administration of MPTP are mainly due to the selective depletion of dopaminergic neurons in the nigrostriatal system as the histological and biochemical data show. The immediate onset of PS deprivation and the PS recovery, despite the definite cell loss, suggests a mechanism independent of cell destruction. In our present study we investigated the occasional histological and the PS-deprivatory effect of a single low dose of MPTP in cats. A single injection of 2 mg/kg MPTP i.p. resulted in PS deprivation lasting for 2.5–3.5 h. The duration of other sleep stages showed no significant change and PS recovery was without rebound phenomenon, as in the case of repeated administration. Even a higher single dose of MPTP (5 mg/kg) resulted in no visibly detectable nigrostriatal cell loss. We suggest that the changes in monoamine release and/or turnover are involved in the PS deprivatory effect of MPTP.
Similar content being viewed by others
References
Chiba K, Trevor AJ, Castagnoli N (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Comm 120:574–578
Chiueh CC, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ (1984) Neurochemical and behavioral effect of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine in the rat. Eur J Pharmacol 100:189–194
Herkenham M, Little MD, Bankiewicz K, Yang SC, Johannessen JN (1991) Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40:133–158
Hobson JA, Lydic R, Baghdoyan KA (1986) Evolving concepts of sleep cycle generation: from brain centers to neuronal populations. Behav Brain Sci 9:371–448
Irwin I, Langston JW (1985) Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity? Life Sci 36:207–212
Jawitch JA, Snyder SH (1985) Uptake of MPP+ by dopamine neurons explains selectivity of parkinsonism inducing neurotoxin MPTP. Eur J Pharmacol 106:455–456
Jones BE (1991) Paradoxical sleep and its structural/chemical substrates in the brain. Neuroscience 40:637–656
Kopin IJ (1987) MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new area in research on Parkinson's disease. Environ Health Perspect 75:45–51
Langston JW (1985) MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 36:201–206
Langston JW, Irwin I (1986) MPTP: current concepts and controversies. Clin Neuropharmacol 9:485–507
Langston JW, Irwin I, Langston EB, Forno L (1984) 1-methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 214:1370–1372
Markey SP, Schmuff NR (1986) The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3–6-tetrahydropyridine) and structurally related compounds. Med Res Rev 6:389–429
Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADHlinked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503–2508
Poirier J (1987) Pathophysiology and biochemical mechanisms involved in MPTP-induced parkinsonism. J Am Geriatr Soc 35:660–668
Pungor K, Papp M, Kékesi K, Juhász G (1990) A novel effect of MPTP: the selective deprivation of paradoxical sleep in cats. Brain Res 525:310–314
Schneider JS, Yuwiler A, Markham CH (1986) Production of a Parkins-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology and biochemistry. Exp Neurol 91:293–307
Singer TP, Ramsay RR (1990) Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett 274:1–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pungor, K., Hajnal, A., Kékesi, K.A. et al. Paradoxical sleep deprivatory effect of a single low dose of MPTP which did not produce dopaminergic cell loss. Exp Brain Res 95, 473–476 (1993). https://doi.org/10.1007/BF00227140
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00227140